Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-28

Clinical Trial Update: Auranofin PK Following Oral Dose Administration [Phase 1]

View source ↗

Summary

Phase 1 study reports the pharmacokinetics of oral Auranofin in Amoebiasis; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Auranofin (Ridaura) (auranofin)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Amoebiasis | Phase 1 | Status: COMPLETED